Watch CBS News

FDA Links Popular Flea, Tick Medications To Neurological Problems In Dogs, Cats

Follow CBSPHILLY Facebook  | Twitter

PHILADELPHIA (CBS Local) -- Some flea and tick medications can cause adverse reactions in dogs and cats, the U.S. Food and Drug Administration warned Thursday.

Some animals receiving drugs in the isoxazoline class, including products sold under the brand names Bravecto, Nexgard and Simparica, have experienced adverse events such as muscle tremors, ataxia and seizures, the FDA says.

Study Shows Octopuses Given Ecstasy Get All Cuddly

"Another product in this class, Credelio, recently received FDA approval. These products are approved for the treatment and prevention of flea infestations, and the treatment and control of tick infestations," the FDA said in a statement.

While the FDA says the medications are still considered safe, it nevertheless issued an alert to owners and veterinarians.

Teen Girl Stabs 13-Year-Old Boy With Scissors At North Philadelphia School, Police Say

The FDA says it was also working with manufacturers of isoxazoline products to include new label information to highlight neurologic events.

"The agency is asking the manufacturers to make the changes to the product labeling in order to provide veterinarians and pet owners with the information they need to make treatment decisions for each pet on an individual basis," the FDA said.

Google Doodles Honors Mister Rogers

The FDA says if your dog or cat experiences an adverse reaction, you should contact your veterinarian.

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.